Numerated Growth Technologies, Inc. – Trademark Portfolio
Entity Type: 03
Numerated Growth Technologies, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NUMERATED. The owner is based in Boston, MA.
265 Franklin Street, Floor 3
Boston, MA 02210
Showing of trademarks Trademarks
Trademark Classifications
Numerated Growth Technologies, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Numerated Growth Technologies, Inc. have?
Numerated Growth Technologies, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does Numerated Growth Technologies, Inc. file in?
Numerated Growth Technologies, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Numerated Growth Technologies, Inc.'s most well-known trademarks?
Numerated Growth Technologies, Inc.'s registered trademark portfolio includes well-known marks such as NUMERATED. These are among 1 currently registered trademark in the portfolio.
What is Numerated Growth Technologies, Inc.'s trademark registration success rate?
Numerated Growth Technologies, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.